Physician profile
Michelle Dougherty
NPI 1396935433
$235,972.65
in general payments reported to CMS, 2019-2025
9 companies · $149K in 2025
The $149K reported for 2025 was more than what 99% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $155 · 2021: $25.00 · 2024: $87K · 2025: $149K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $235K · Gift: $522.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $235,270.17 |
| Gift | $521.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ceribell, INC. | $235,792.16 | 2024-2025 | Pocket Eeg Device |
| E.R. Squibb & Sons, L.L.C. | $42.40 | 2020 | |
| Celgene Corporation | $25.00 | 2021 | |
| Biogen, INC. | $24.39 | 2020 | |
| Abbvie INC. | $22.82 | 2020 | |
| Sunovion Pharmaceuticals INC. | $20.34 | 2020 | |
| Mdd US Operations, LLC | $17.39 | 2020 | |
| Neurocrine Biosciences, INC. | $17.04 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $11.11 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Dougherty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.